1. 2017 Annual Data Report
Healthy People 2020

2. HP2020 Table A HP2020 CKD Objectives
Indicator
Target
CKD-1*
Reduce the proportion of the U.S. population with chronic kidney disease
13.3%
CKD-2*
Increase the proportion of persons with chronic kidney disease (CKD) who know they have impaired renal function
13.4%
CKD-3
Increase the proportion of hospital patients who incurred acute kidney injury who have follow-up renal evaluation in 6 months post discharge
12.3%
CKD-4 Increase the proportion of persons with diabetes and chronic kidney disease who receive recommended medical evaluation
4.1 Increase the proportion of persons with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and microalbuminuria
28.4%
4.2 Increase the proportion of persons with type 1 or type 2 diabetes and chronic kidney disease who receive medical evaluation with serum creatinine, microalbuminuria, A1c, lipids, and eye examinations
25.3%
CKD-5
Increase the proportion of persons with diabetes and chronic kidney disease who receive recommended medical treatment with angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBS)
76.3%
CKD-6* Improve cardiovascular care in persons with chronic kidney disease
6.1 Reduce the proportion of persons with chronic kidney disease who have elevated blood pressure
17.6%
6.2 Increase the proportion of adults aged 50 years and over with chronic kidney disease who currently take statins to lower their blood cholesterol
25.6%
CKD-7*
Reduce the number of deaths among persons with chronic kidney disease
Not applicable
CKD-8
Reduce the number of new cases of end-stage renal disease (ESRD)
352.0 PMP
CKD-9 Reduce kidney failure due to diabetes
9.1 Reduce kidney failure due to diabetes
154.4 PMP
9.2 Reduce kidney failure due to diabetes among persons with diabetes
PMP
CKD-10
Increase the proportion of chronic kidney disease patients receiving care from a nephrologist at least 12 months before the start of renal replacement therapy
30.0%
CKD-11 Improve vascular access for hemodialysis patients
11.1 Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access
50.6%
11.2 Reduce the proportion of adult hemodialysis patients who use catheters as the only mode of vascular access
26.1%
11.3 Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas or have a maturing fistula as the primary mode of vascular access at the start of renal replacement therapy
34.8%
CKD-12
Increase the proportion of dialysis patients waitlisted and/or receiving a deceased donor kidney transplant within 1 year of end-stage renal disease (ESRD) start (among patients under 70 years of age)
18.7%
CKD-13 Increase the proportion of patients with treated chronic kidney failure who receive a transplant
13.1 Increase the proportion of patients receiving a kidney transplant within 3 years of end-stage renal disease (ESRD)
20.1%
13.2 Increase the proportion of patients who receive a preemptive transplant at the start of ESRD
CKD-14 Reduce deaths in persons with end-stage renal disease (ESRD)
14.1 Reduce the total number of deaths for persons on dialysis
187.4 per 1000 patient years
14.2 Reduce the number of deaths in dialysis patients within the first 3 months of initiation of renal replacement therapy
335.0 per 1000 patient years
14.3 Reduce the number of cardiovascular deaths for persons on dialysis
81.3 per 1000 patient years
14.4 Reduce the total number of deaths for persons with a functioning kidney transplant
27.8 per 1000 patient years
14.5 Reduce the number of cardiovascular deaths in persons with a functioning kidney transplant
4.5 per 1000 patient years
Data Source: althypeople.gov /2020/topics- objectives/topic /chronic-kidney- disease/objectiv es. Abbreviation: PMP, per million population. * These objectives use a data source other than USRDS, and are therefore not reported in this chapter.
2017 Annual Data Report
Volume 3 HP2020

3. HP2020 Table 1 CKD-3 Increase the proportion of hospital patients who incurred acute kidney injury who have follow-up renal evaluation in 6 months post discharge: Target 12.3%
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014 (%)
2015 (%)
All
10.4
11.2
10.5
11.4
11.8
12.6
12.7
15.9
16.2
17.4
Race/Ethnicity
American Indian or Alaska Native
13.2
12.0
15.2
6.9
11.1
9.5
9.3
10.2
17.5
Asian
19.2
15.1
11.3
16.1
15.3
16.0
14.7
22.5
20.8
19.1
Black/African American
9.0
12.1
15.8
17.0
18.9
White
12.5
15.6
16.9
Hispanic or Latino
10.1
13.1
12.9
16.6
23.1
22.4
24.7
Sex
Male
11.9
12.4
13.8
13.9
18.6
Female
9.7
10.0
11.0
11.5
11.7
14.6
15.0
Age
65-74
14.8
16.5
17.3
21.0
22.1
75-84
10.7
12.3
13.0
16.7
17.2
18.2
85+
5.1
5.0
6.4
5.9
6.2
8.8
8.6
Data Source: Special analyses, Medicare 5 percent sample. Medicare patients aged 65 & older with a hospitalized AKI event in a given year. Abbreviation: CKD, chronic kidney disease.

4. HP2020 Table 2 D-12 Increase the proportion of persons with diagnosed diabetes who obtain an annual urinary microalbumin measurement: Target 37.0%
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
31.3
33.6
35.6
37.3
38.8
40.7
42.6
45.0
46.2
47.6
Race/Ethnicity
American Indian or Alaska Native
19.8
21.2
21.5
24.2
23.8
24.9
24.3
27.6
27.8
30.1
Asian
33.8
35.2
37.5
39.8
42.1
43.9
47.5
49.3
50.4
53.4
Black/African American
29.5
31.9
33.7
35.7
37.0
39.3
41.0
43.1
43.8
46.0
White
31.4
35.8
37.4
38.9
40.8
44.9
46.3
Hispanic or Latino
31.5
38.1
40.4
44.3
48.0
48.8
50.5
Sex
Male
32.2
34.6
36.6
38.2
41.7
43.4
47.3
48.6
Female
30.5
32.7
34.8
36.5
38.0
39.9
41.9
44.0
45.2
46.8
Age
65-74
37.7
40.0
43.3
45.3
47.2
49.5
50.6
51.9
75-84
29.6
31.8
35.3
37.1
39.1
44.4
45.8
85+
18.1
20.5
22.2
23.5
25.0
26.7
28.0
32.5
34.1
Data Source: Special analyses, Medicare 5 percent sample. Medicare patients with diabetes mellitus, aged 65 & older. Abbreviation: D, diabetes mellitus.

5. HP2020 Table 3 CKD-4.1 Increase the proportion of persons with chronic kidney disease who receive medical evaluation with serum creatinine, lipids, and microalbuminuria: Target 28.4%
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
23.5
25.8
26.8
28.2
29.1
30.3
31.2
33.1
33.7
33.8
Race/Ethnicity
American Indian or Alaska Native
15.6
17.2
17.4
18.6
20.2
21.0
18.5
23.3
22.0
24.2
Asian
32.9
35.3
34.0
37.8
37.1
39.6
41.2
43.8
44.9
45.3
Black/African American
24.5
28.0
30.2
30.6
32.3
33.0
35.0
35.5
35.8
White
22.9
25.2
26.3
27.4
28.4
29.5
30.4
32.2
32.8
Hispanic or Latino
31.5
36.2
36.7
39.3
41.5
44.1
44.7
44.3
Sex
Male
24.6
27.2
29.6
32.0
35.7
35.6
Female
22.4
24.4
25.3
27.7
28.8
31.4
32.1
Age
65-74
31.7
35.4
37.0
37.9
39.1
39.9
42.0
41.3
75-84
23.7
26.2
27.3
28.9
30.1
32.7
34.8
85+
11.1
13.0
14.2
15.1
15.9
18.0
19.8
20.6
Data Source: Special analyses, Medicare 5 percent sample. Medicare patients aged 65 & older with CKD. Abbreviation: CKD, chronic kidney disease.

6. HP2020 Table 4 CKD-4.2 Increase the proportion of persons with type 1 or type 2 diabetes and chronic kidney disease who receive medical evaluation with serum creatinine, microalbuminuria, A1c, lipids, and eye examinations: Target 25.3%
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
21.2
23.0
23.6
25.1
26.5
26.9
27.6
29.7
29.8
30.1
Race/Ethnicity
American Indian or Alaska Native
12.4
10.4
11.5
11.7
15.1
14.1
17.1
17.2
18.0
Asian
26.2
26.6
25.3
27.1
29.5
30.7
32.6
37.0
34.4
32.9
Black/African American
18.8
19.7
21.0
22.4
23.7
25.0
27.0
White
21.4
23.5
24.1
25.6
27.8
30.2
Hispanic or Latino
20.3
22.0
21.9
24.6
25.4
30.0
32.1
Sex
Male
25.5
26.7
27.2
27.7
30.4
Female
20.9
22.5
24.7
27.4
29.4
Age
65-74
26.4
28.3
29.9
32.2
32.4
75-84
23.3
25.9
27.3
28.0
29.3
31.6
31.5
31.7
85+
12.3
15.0
16.6
17.6
18.7
18.9
21.7
22.3
Data Source: Special analyses, Medicare 5 percent sample. Medicare patients aged 65 & older with CKD & diabetes mellitus. Abbreviations: CKD, chronic kidney disease; A1c, glycosylated hemoglobin.

7. HP2020 Table 5 CKD-5 Increase the proportion of persons with diabetes and chronic kidney disease who receive recommended medical treatment with angiotensin- converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBS): Target 76.3
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
63.6
69.4
70.1
71.1
70.6
70.4
70.7
71.6
72.0
Race/Ethnicity
American Indian or Alaska Native
60.2
70.5
75.6
77.2
73.7
71.9
72.5
70.8
74.4
Asian
70.3
76.4
77.0
76.0
78.0
76.5
78.5
79.4
77.8
Black/African American
66.7
71.4
72.6
71.5
71.8
72.3
72.7
White
62.2
68.3
69.3
70.2
69.7
69.8
71.2
Hispanic or Latino
69.1
73.2
73.0
75.5
77.5
79.3
77.6
77.1
Sex
Male
60.4
66.9
68.4
68.9
68.5
69.6
Female
65.8
71.3
72.4
72.8
Age
65-74
67.3
73.3
73.9
74.6
74.0
74.7
75.3
75.4
75-84
68.2
69.2
70.0
85+
56.7
61.5
62.1
64.2
62.4
61.7
64.0
63.8
62.3
Data Source: Special analyses, Medicare 5 percent sample. Medicare patients aged 65 & older with CKD & diabetes mellitus. Abbreviation: CKD, chronic kidney disease.

8. HP2020 Table 6 CKD-8 Reduce the rate of new cases of end-stage renal disease (ESRD): Target new cases per million population
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
398.9
391.1
386.7
389.9
382.0
365.8
360.0
360.5
360.9
361.6
Race
American Indian or Alaska Native
526.9
541.3
544.0
528.5
488.2
459.0
465.4
414.3
407.2
376.0
Asian
355.4
357.3
355.9
366.2
355.7
347.4
338.2
336.1
326.3
314.9
Native Hawaiian or Pacific Islander~
2846.9
2402.3
2203.9
2433.0
2608.7
2381.0
2552.9
2599.5
2558.4
2516.7
Black/African American
1114.4
1092.1
1073.3
1072.9
1033.2
993.3
949.6
936.0
917.5
895.0
White
312.1
306.6
304.2
307.8
304.3
291.3
287.7
289.1
291.2
294.0
Two or more races
147.5
149.3
158.4
145.1
140.6
115.2
13.7 *
Ethnicity
Hispanic/Latino
610.5
593.6
589.7
586.4
579.6
566.8
533.0
525.9
498.7
492.0
Non-Hispanic
382.5
375.9
372.3
377.1
369.9
354.3
354.5
360.6
364.0
Non-Hispanic Black/African American
1132.6
1111.7
1093.1
1093.4
1053.9
1013.0
972.2
960.7
945.2
922.6
Non-Hispanic White
281.3
275.8
272.1
275.3
270.9
257.0
256.4
258.0
262.3
265.9
Sex
Male
494.1
486.8
483.8
489.0
480.9
460.9
452.8
456.2
457.5
457.7
Female
322.4
314.8
309.1
310.5
302.6
288.4
284.6
282.7
281.6
Age
<18
11.6
12.3
12.2
12.0
11.7
11.5
10.8
10.2
0-4
8.9
10.9
10.0
11.0
11.2
11.3
11.1
10.7
5-11
6.6
7.0
7.8
7.2
7.5
7.9
7.1
5.3
12-17
19.6
19.5
19.2
18.6
17.2
17.5
16.8
16.0
15.3
15.5
18-44
120.9
119.3
118.8
122.5
113.9
115.0
119.8
120.2
18-24
43.5
43.0
41.4
40.7
39.9
39.6
36.2
37.2
34.7
35.2
25-44
148.0
146.1
145.8
151.1
146.4
141.7
141.1
142.2
149.5
150.0
45-64
611.5
597.1
592.4
592.8
575.3
556.3
557.1
557.0
557.5
559.4
45-54
402.8
390.0
386.3
389.0
373.6
371.9
369.6
386.1
393.8
55-64
820.3
804.1
798.5
796.6
777.0
740.7
744.6
731.4
728.9
725.1
65+
1655.7
1623.5
1599.6
1609.4
1600.6
1520.3
1460.8
1459.9
1435.7
1436.5
65-74
1414.5
1379.3
1351.8
1359.3
1352.7
1269.9
1238.5
1244.3
1235.2
1214.9
75-84
1914.4
1879.1
1855.0
1865.6
1860.8
1786.4
1698.1
1697.8
1659.3
1685.1
85+
1480.8
1510.2
1523.3
1548.6
1478.4
1364.8
1310.2
1237.3
1205.2
1166.0
Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset, Incident ESRD patients. Rates adjusted for: overall, age/sex/race; rates by age adjusted for sex/race; rates by sex adjusted for age/race; rates by race/ethnicity adjusted for age/sex. Standard population: patients. “.” Zero values in this cell. ~Estimate shown is imprecise due to small sample size and may be unstable over time. Abbreviations: CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease.

9. HP2020 Table 7 CKD-9.1 Reduce kidney failure (or end-stage renal disease, ESRD) due to diabetes: Target per million population
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
177.4
171.5
168.9
169.6
166.8
159.8
157.9
159.3
160.5
164.1
Race
American Indian or Alaska Native
367.7
380.7
390.3
383.5
347.6
321.3
322.5
299.3
290.3
275.8
Asian
172.8
179.9
180.5
172.5
173.3
170.3
172.6
170.5
163.3
Native Hawaiian or Pacific Islander~
1737.2
1504.7
1327.4
1530.7
1642.6
1450.8
1517.6
1674.4
1642.9
1606.5
Black/African American
502.3
478.3
473.2
471.2
456.4
436.0
412.0
401.8
396.2
393.5
White
139.6
136.2
134.0
135.1
134.4
129.3
130.0
133.0
135.0
139.8
Two or more races
74.2
81.4
78.4
76.2
68.4
58.4
6.6 . *
Ethnicity
Hispanic/Latino
377.3
367.2
367.6
359.9
355.9
346.8
324.5
318.8
305.3
302.6
Non-Hispanic
158.6
156.2
157.7
155.1
148.3
147.8
149.7
152.1
Non-Hispanic Black/African American
509.7
486.1
481.5
480.0
465.1
444.2
421.5
411.6
407.3
404.6
Non-Hispanic White
116.4
112.9
109.4
110.4
109.2
103.6
105.8
108.7
111.4
116.8
Sex
Male
206.7
202.3
200.6
203.1
193.5
191.2
195.1
198.6
201.8
Female
152.7
145.8
142.4
141.5
138.5
131.4
129.5
129.1
128.2
132.1
Age
<18
0.1
0-4
0.4
5-11
12-17
18-44
38.3
37.8
37.7
39.9
39.6
38.2
39.3
41.8
42.7
18-24
3.2
2.7
2.4
2.6
2.5
2.3
1.8
25-44
50.6
50.1
50.0
53.0
52.6
52.7
50.8
52.2
55.9
56.7
45-64
323.6
309.8
308.1
306.8
295.1
281.9
284.5
282.0
282.6
286.7
45-54
189.6
178.9
178.6
180.3
175.7
173.6
175.5
182.7
183.6
190.3
55-64
457.7
440.8
437.7
433.3
414.5
381.4
381.7
383.2
65+
706.8
691.6
674.1
673.4
679.6
647.5
617.2
629.1
626.9
644.1
65-74
725.6
697.8
677.7
674.8
669.0
632.5
613.6
622.0
617.0
611.7
75-84
722.7
717.9
700.3
700.4
720.1
691.5
647.7
665.9
666.0
85+
376.7
390.4
381.6
358.5
349.2
332.5
335.7
341.0
Data Source:
Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset, Incident ESRD patients. Adjusted for age/sex/race; standard population: “.” Zero values in this cell. *Values for cells with 10 or fewer patients are suppressed. ~Estimate shown is imprecise due to small sample size and may be unstable over time. Abbreviations: CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease.

10. HP2020 Table 8 CKD-9.2 Reduce kidney failure (or end-stage renal disease, ESRD) due to diabetes among persons with diabetes: Target 2,354.4 per million population
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
2616
2486
2401
2344
2271
2264
2297
2306
2378
Race
American Indian or Alaska Native
2559
2926
2931
2594
2246
2286
2034
1742
1719
Asian
2067
2185
2207
2106
2070
2164
2311
2252
Native Hawaiian or Pacific Islander~
N/A
Black/African American
4476
4335
4242
3978
3820
3704
3582
3572
3497
White
2276
2138
2047
2025
1971
1983
2036
2055
2148
Two or more races
610
553
517
484
463 52 . *
Ethnicity
Hispanic/Latino
3313
3177
2960
2898
2900
2810
2808
2719
2728
Non-Hispanic
2518
2391
2321
2261
2179
2176
2211
2230
2304
Non-Hispanic Black/African American
4686
4528
4473
4191
4057
3910
3770
3779
3725
Non-Hispanic White
2049
1899
1822
1799
1729
1762
1825
1855
1965
Sex
Male
2927
2744
2621
2541
2521
2540
2608
2622
2688
Female
2327
2235
2177
2139
2019
1990
1988
1985
2064
Age
<18 30 35 42 57 90
0-4
5-11 22
12-17 21 34 27
18-44
1613
1531
1507
1461
1557
1515
1562
1712
1709
18-24
341
268
285
290
334
294
281
205
25-44
1748
1677
1642
1578
1665
1651
1714
1877
45-64
2377
2257
2195
2134
2068
2116
2129
2144
2216
45-54
2005
1846
1854
1864
1875
1887
1963
1972
2038
55-64
2643
2571
2436
2308
2227
2243
2318
65+
3101
2939
2800
2720
2574
2508
2558
2504
2587
65-74
3186
2990
2894
2771
2619
2565
2624
2564
2533
75-84
3351
3156
2934
2873
2799
2721
2854
3070
85+
1946
2073
1976
1765
1695
1508
1517
1654
Data Source: Special analyses, USRDS ESRD Database and CDC Bridged Race Intercensal Estimates Dataset, Incident ESRD patients. Adjusted for age/sex/race; Standard population National Health Interview Survey 2006–2015 used to estimate diabetes mellitus prevalence. “.” Zero values in this cell; *Values for cells with 10 or fewer patients are suppressed. Abbreviations: CDC, Centers for Disease Control and Prevention; CKD, chronic kidney disease.

11. HP2020 Table 9 CKD-10 Increase the proportion of chronic kidney disease patients receiving care from a nephrologist at least 12 months before the start of renal replacement therapy: Target 30.4%
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015 (%)
All
26.4
27.3
28.6
29.5
31.0
33.1
34.2
34.9
35.6
Race
American Indian or Alaska Native
25.9
27.9
26.9
23.8
27.6
30.4
30.2
30.1
Asian
23.9
26.6
27.5
29.1
29.7
31.4
31.6
35.4
35.5
37.6
Native Hawaiian or Pacific Islander
25.2
24.0
22.5
27.0
27.1
29.9
32.2
31.5
Black/African American
23.2
24.7
24.9
25.5
27.2
29.6
30.7
32.0
White
28.8
30.3
31.3
32.7
34.7
35.9
36.6
37.0
Two or more races
22.7
24.6
29.2 *
Ethnicity
Hispanic/Latino
21.1
21.2
22.2
23.6
25.0
25.6
28.1
Non-Hispanic
28.2
30.6
32.1
34.4
36.3
36.9
Non-Hispanic Black/African American
24.1
24.8
30.8
Non-Hispanic White
29.4
30.5
32.3
33.3
37.1
38.2
39.2
39.3
Sex
Male
26.5
28.4
28.3
34.1
Female
28.9
34.3
35.2
Age
<18
39.4
38.5
36.8
44.2
40.8
46.1
43.1
48.3
0-4
20.5
22.3
22.6
25.4
27.7
5-11
47.6
40.4
51.7
59.1
58.1
52.9
57.2
12-17
36.2
41.3
46.3
42.2
49.0
47.3
55.5
18-44
22.9
23.5
24.4
24.2
27.8
29.3
18-24
25.3
25-44
23.4
24.5
45-64
26.1
27.4
31.1
33.5
45-54
25.7
26.3
31.2
55-64
29.0
33.0
34.5
65+
28.7
33.4
35.8
37.2
38.6
65-74
35.7
37.9
38.1
75-84
30.9
33.9
38.3
38.8
39.6
85+
26.7
34.0
37.7
Data Source: Special analyses, USRDS ESRD Database. Incident patients with a valid ESRD Medical Evidence CMS 2728 form; nephrologist care determined from Medical Evidence form. Abbreviations: CMS, Centers for Medicare and Medicaid Services; ESRD, end-stage renal disease.

12. HP2020 Figure 1 CKD-10: Geographic distribution of the adjusted proportion of chronic kidney disease patients receiving care from a nephrologist at least 12 months before the start of renal replacement therapy, by state, in the U.S. population, 2015: Target 30.4%
Data Source: Special analyses, USRDS ESRD Database. Incident hemodialysis patients with a valid ESRD Medical Evidence CMS 2728 form; nephrologist care determined from Medical Evidence form. Adjusted for age, sex, and race. Abbreviations: CKD, chronic kidney disease; CMS, Centers for Medicare and Medicaid Services; ESRD, end-stage renal disease.

13. HP2020 Table 10 CKD-11.1: Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas as the primary mode of vascular access: Previous data source target 50.6%
2012 (%)
2013 (%)
2014 (%)
2015 (%)
All
62.0
63.5
64.1
63.8
Race
American Indian or Alaska Native
72.4
75.0
75.6
76.4
Asian
66.9
68.7
69.1
68.6
Native Hawaiian or Pacific Islander
65.7
69.4
69.3
Black/African American
57.5
58.8
59.5
59.2
White
64.3
65.8
66.3
65.9
Two or more races
70.1
69.8
71.6
71.1
Ethnicity
Hispanic/Latino
67.9
68.8
69.2
69.0
Non-Hispanic
60.7
62.3
62.9
62.7
Non-Hispanic Black/African American
57.4
59.4
Non-Hispanic White
62.6
64.4
64.9
64.5
Sex
Male
68.3
69.5
69.6
Female
54.0
55.8
56.6
56.3
Age
18-44
66.2
67.0
67.6
18-24
65.2
67.1
68.4
67.2
25-44
67.5
45-64
63.9
65.4
45-54
67.7
55-64
64.2
64.7
65+
57.7
60.1
60.0
65-74
59.8
61.6
62.1
75-84
58.1
58.9
58.6
85+
46.2
48.8
49.3
49.2
Data Source: Special analyses, CROWNWeb. Prevalent hemodialysis patients with a valid ESRD Medical Evidence CMS 2728 form, vascular access type determined from CROWNWeb. Abbreviations: CMS, Centers for Medicare and Medicaid Services; ESRD, end-stage renal disease.

14. HP2020 Table 11 CKD-11.2: Reduce the proportion of adult hemodialysis patients who use catheters as the only mode of vascular access: Previous data source target 26.1%
2012 (%)
2013 (%)
2014 (%)
2015 (%)
All
15.2
14.6
16.2
16.3
Race
American Indian or Alaska Native
12.3
11.5
12.4
Asian
13.2
12.7
13.4
13.3
Native Hawaiian or Pacific Islander
14.2
14.0
14.1
Black/African American
14.4
13.7
15.1
15.3
White
16.1
15.4
17.3
17.4
Two or more races
9.6
9.2
8.0
9.1
Ethnicity
Hispanic/Latino
12.9
14.5
Non-Hispanic
15.7
15.0
16.6
16.7
Non-Hispanic Black/African American
Non-Hispanic White
18.6
18.7
Sex
Male
12.8
Female
17.7
16.8
18.4
Age
18-44
13.8
18-24
17.5
15.8
17.8
25-44
13.5
15.5
45-64
45-54
55-64
14.7
15.6
65+
17.0
18.1
65-74
16.9
75-84
17.1
85+
27.0
25.5
27.1
27.2
Data Source: Special analyses, CROWNWeb. Prevalent hemodialysis patients with a valid ESRD Medical Evidence CMS form, vascular access type determined from CROWNWeb. Abbreviations: CMS, Centers for Medicare and Medicaid Services; ESRD, end-stage renal disease.

15. HP2020 Table 12 CKD-11.3 Increase the proportion of adult hemodialysis patients who use arteriovenous fistulas or have a maturing fistula as the primary mode of vascular access at the start of renal replacement therapy: Target 34.8%
2006 (%)
2007
(%)
2008
2009
2010
2011
2012
2013
2014
2015
All
31.8
31.6
31.2
32.2
33.8
35.1
36.7
37.3
35.9
35.5
Race
American Indian or Alaska Native
39.0
37.7
41.5
41.4
41.1
40.4
40.8
42.5
43.2
Asian
35.2
37.2
38.0
41.3
38.5
38.6
Native Hawaiian or Pacific Islander
34.7
32.8
32.4
32.7
36.2
37.4
39.9
34.8
37.5
Black/African American
29.3
29.7
29.2
30.6
32.1
33.9
35.8
35.7
34.3
33.3
White
31.7
35.3
36.8
36.0
Two or more races
36.3
33.0
28.8
37.6 *
Ethnicity
Hispanic/Latino
32.3
29.9
30.9
33.4
34.0
33.1
Non-Hispanic
31.9
31.4
32.5
35.4
37.1
Non-Hispanic Black/African American
29.1
30.5
32.0
Non-Hispanic White
32.9
33.2
36.9
Sex
Male
35.0
34.9
36.4
37.9
39.2
39.3
Female
27.8
27.5
27.6
30.4
34.5
Age
18-44
28.2
27.4
31.1
32.6
18-24
21.9
20.8
21.1
22.6
23.4
24.9
25.8
22.8
25-44
30.1
28.9
28.1
29.8
33.5
31.5
45-64
34.4
36.5
45-54
34.1
55-64
38.3
36.1
65+
31.0
65-74
34.2
37.0
38.8
75-84
30.8
33.7
85+
25.2
25.4
24.3
25.5
26.7
28.5
29.5
Data Source: Special analyses, USRDS ESRD Database. Incident hemodialysis patients aged 18 & older.

16. HP2020 Table 13 CKD-12 Increase the proportion of dialysis patients waitlisted and/or receiving a kidney transplant from a deceased donor within 1 year of end-stage renal disease (ESRD) start (among patients under 70 years of age): Target 18.7% of dialysis patients
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
16.9
17.0
16.8
17.1
17.4
17.3
16.7
15.7
Race
American Indian or Alaska Native
10.3
11.4
10.6
11.1
12.3
11.8
8.8
9.9
Asian
31.4
30.8
31.0
31.9
31.6
32.8
31.7
30.2
28.7
Native Hawaiian or Pacific Islander
14.9
14.3
14.8
15.1
14.5
16.3
17.8
15.0
12.9
Black/African American
13.1
13.3
13.2
13.9
13.8
14.4
14.7
14.6
14.1
12.8
White
18.5
18.2
17.7
18.3
18.1
18.0
17.5
16.4
Two or more races
19.5
13.6
23.7
24.3
22.4
18.6 *
20.0
Ethnicity
Hispanic/Latino
17.6
17.9
18.4
16.0
15.5
Non-Hispanic
16.5
16.6
Non-Hispanic Black/African American
13.0
13.7
14.0
12.7
Non-Hispanic White
18.7
18.8
Sex
Male
Female
15.8
15.9
16.2
16.1
15.3
Age
<18
59.5
57.0
61.0
58.9
57.1
55.6
57.4
59.1
61.3
52.0
0-4
43.0
36.7
42.5
46.2
40.8
37.4
34.8
37.2
33.2
29.0
5-11
65.3
66.5
69.1
65.5
63.1
63.2
68.7
73.7
60.2
12-17
62.9
60.6
64.4
62.1
60.0
64.9
63.9
68.8
62.5
18-44
26.3
25.8
25.3
25.0
26.7
25.6
24.9
23.6
18-24
32.3
29.6
32.1
32.2
32.6
33.9
33.5
25-44
25.7
25.2
26.2
24.7
24.1
22.7
45-64
15.6
15.4
45-54
55-64
14.2
65+
9.0
9.4
10.9
10.8
11.6
11.5
10.5
65-69
Data Source: Special analyses, USRDS ESRD Database. Incident ESRD patients younger than age 70.

17. HP2020 Table 14 CKD-13.1 Increase the proportion of patients receiving a kidney transplant within 3 years of end-stage renal disease (ESRD): Target 20.1%
2003 (%)
2004 (%)
2005 (%)
2006 (%)
2007 (%)
2008 (%)
2009 (%)
2010 (%)
2011 (%)
2012 (%)
All
18.1
18.3
17.8
17.2
16.5
15.6
14.7
14.1
13.8
13.2
Race
American Indian or Alaska Native
8.8
9.3
8.7
10.0
10.1
7.0
7.2
6.4
Asian
22.1
20.6
18.6
19.1
17.5
18.0
16.9
17.6
17.0
16.2
Native Hawaiian or Pacific Islander
11.7
12.7
9.8
9.6
10.5
11.1
8.3
7.5
8.0
8.1
Black/African American
9.2
9.1
9.0
7.7
7.6
7.3
White
23.0
22.7
22.2
21.4
19.3
Two or more races
17.1
16.6
17.9
18.4
14.9
17.7
Ethnicity
Hispanic/Latino
14.8
15.0
14.0
12.8
11.8
11.3
11.4
11.0
Non-Hispanic
17.3
16.8
15.9
14.3
13.9
Non-Hispanic Black/African American
9.9
9.5
8.9
8.6
6.9
Non-Hispanic White
25.4
25.0
24.4
23.7
21.6
20.4
19.4
19.0
Sex
Male
19.7
19.6
19.2
18.5
15.3
14.5
13.5
Female
16.1
15.4
12.9
Age
<18
78.1
76.3
76.7
78.3
74.6
75.1
74.4
0-4
79.8
75.5
77.3
75.9
68.7
76.9
71.2
69.1
62.5
5-11
83.8
84.1
82.1
83.0
86.9
85.6
81.1
84.0
12-17
72.5
76.8
76.0
76.2
73.3
73.4
75.7
18-44
28.9
29.3
27.7
26.7
23.9
22.6
21.8
21.2
18-24
42.5
42.2
40.4
37.3
35.2
33.1
34.1
33.8
30.6
31.9
25-44
27.4
27.8
26.3
25.6
24.2
22.8
20.5
20.3
20.1
45-64
15.2
12.3
11.5
45-54
13.4
55-64
12.4
12.6
13.1
11.9
11.6
10.7
10.3
65+
7.9
8.4
65-69
Data Source: Special analyses, USRDS ESRD Database. Incident ESRD patients younger than age 70,

18. HP2020 Figure 2 HP2020 CKD-13.1 Geographic distribution of the adjusted proportion of patients receiving a kidney transplant within 3 years of end-stage renal disease (ESRD), by state, in the U.S. population, 2012: Target 20.1%
Data Source: Special analyses, USRDS ESRD Database. Incident ESRD patients younger than age 70. Adjusted for age, sex, and race. Alaska, Hawaii, and Wyoming are not reported due to small sample size.

19. HP2020 Table 15 CKD-13.2 Increase the proportion of patients who receive a preemptive transplant at the start of end-stage renal disease (ESRD): No applicable target
2006
(%)
2007
2008
2009
2010
2011
2012
2013
2014
2015 (%)
All
4.1
4.0
3.9
3.8
3.6
3.7
Race
American Indian or Alaska Native
1.5
1.2 *
1.7
1.6
1.3
1.4
Asian
3.0
3.2
3.5
3.3
4.5
Native Hawaiian or Pacific Islander
1.9
2.8
Black/African American
1.0
1.1
0.9
White
5.2
5.3
5.0
4.7
4.8
4.4
4.2
Two or more races
Ethnicity
Hispanic/Latino
2.3
2.2
2.1
2.4
2.0
Non-Hispanic
Non-Hispanic Black/African American
Non-Hispanic White
6.1
6.3
6.0
5.5
5.7
5.1
Sex
Male
Female
Age
<18
24.0
21.2
20.9
24.9
22.5
24.3
22.9
26.8
0-4
17.6
19.7
10.6
18.8
15.0
18.4
17.4
14.2
16.0
5-11
32.1
30.7
33.0
31.2
28.3
30.0
31.8
38.0
12-17
23.2
18.1
24.1
21.8
24.7
24.4
23.1
22.7
28.1
18-44
6.4
5.9
5.4
5.8
18-24
10.0
8.1
8.6
8.9
8.7
9.2
9.0
8.0
10.3
9.5
25-44
45-64
3.4
3.1
45-54
4.3
4.6
55-64
2.9
2.7
65+
1.8
65-69
Data Source: Special analyses, USRDS ESRD Database. Incident ESRD patients younger than age 70. *Values for cells with 10 or fewer patients are suppressed.

20. HP2020 Table 16 CKD-14.1 Reduce the total number of deaths for persons on dialysis: Target deaths per 1,000 patient years
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
216.7
208.2
200.9
195.7
188.8
184.8
177.5
173.7
172.0
174.4
Race
American Indian or Alaska Native
171.1
163.2
167.5
169.7
152.1
146.0
145.2
143.4
150.3
152.9
Asian
153.7
150.7
137.8
139.2
130.8
133.1
128.1
122.9
124.3
126.4
Native Hawaiian or Pacific Islander
159.6
157.6
152.4
148.6
135.5
132.4
119.8
124.7
115.5
Black/African American
170.9
164.3
157.9
153.4
145.8
141.0
136.2
133.8
132.2
135.8
White
258.1
247.2
238.9
232.1
225.9
222.4
212.9
208.4
205.5
207.4
Two or more races
162.4
144.6
149.1
144.9
133.2
127.8
120.3
121.3
135.9
119.4
Ethnicity
Hispanic/Latino
156.9
147.0
140.6
140.0
131.7
130.2
130.1
125.5
125.2
128.5
Non-Hispanic
178.8
158.3
135.2
133.0
132.3
129.5
109.0
104.8
100.3
Non-Hispanic Black/African American
164.8
154.0
146.3
141.5
136.0
133.9
132.5
Non-Hispanic White
289.2
279.5
272.3
264.8
260.5
258.0
247.0
242.8
239.4
240.7
Sex
Male
212.5
204.9
198.5
195.0
187.3
183.8
176.8
171.7
170.1
172.6
Female
221.7
212.2
203.8
196.5
190.6
186.1
178.4
176.4
174.5
176.9
Age
<18
43.9
36.8
35.8
41.6
36.5
29.3
31.6
30.0
33.1
25.3
0-4
117.7
86.4
94.8
100.7
77.3
60.1
67.7
65.2
53.0
5-11
34.2
34.7
40.8
49.5
42.8
35.5
34.9
32.5
41.0
28.2
12-17
29.0
24.8
16.8
19.2
20.4
15.6
18.8
12.6
15.4 *
18-44
79.3
75.7
70.8
70.0
63.2
61.3
59.6
57.7
57.3
58.8
18-24
48.8
48.1
39.7
37.6
33.7
32.9
32.6
25-44
81.7
77.9
73.0
72.5
65.3
61.6
59.1
60.6
45-64
160.0
151.2
141.2
135.6
127.2
122.7
122.2
123.5
45-54
131.3
125.4
117.3
113.6
107.0
105.6
98.3
96.3
95.1
95.6
55-64
181.9
170.6
165.3
161.1
155.8
151.0
146.6
140.1
141.7
65+
325.3
315.3
305.9
296.7
287.6
281.6
268.9
263.5
258.3
260.4
65-74
257.6
247.6
242.2
236.9
227.7
221.8
212.7
210.3
208.8
75-84
374.2
361.2
348.9
335.7
326.1
319.5
303.7
297.6
291.7
85+
518.3
513.8
488.0
468.4
457.4
452.6
435.3
423.9
416.0
422.1
Data Source:
Special analyses, USRDS ESRD Database. Period prevalent dialysis patients. *Values for cells with 10 or fewer patients are suppressed.

21. HP2020 Table 17 CKD-14.2 Reduce the number of deaths in dialysis patients within the first 3 months of initiation of renal replacement therapy: Target deaths per 1,000 patient years at risk
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
381.2
372.2
369.6
362.5
362.7
343.5
326.2
322.4
323.0
311.5
Race
American Indian or Alaska Native
174.7
179.0
247.8
174.4
163.5
164.6
227.4
206.1
147.6
134.9
Asian
217.2
247.2
197.1
216.6
217.8
178.9
193.1
188.3
199.2
171.2
Native Hawaiian or Pacific Islander
215.7
169.9
160.8
200.7
163.9
183.3
117.7
161.1
139.8
139.4
Black/African American
272.7
257.7
259.1
251.4
231.4
214.2
223.3
226.4
218.9
White
445.8
439.0
436.2
429.6
431.2
411.8
390.9
380.4
379.6
366.2
Two or more races
308.8
312.6
310.7
219.2
279.5
283.2
248.2 *
Ethnicity
Hispanic/Latino
222.4
222.7
214.6
204.9
208.7
206.5
195.4
184.9
192.6
Non-Hispanic
400.4
391.9
390.0
383.2
384.7
364.4
344.5
344.2
345.1
329.9
Non-Hispanic Black/African American
268.4
256.8
254.9
247.7
247.0
231.2
210.8
222.3
225.7
Non-Hispanic White
494.4
486.8
489.0
482.2
485.7
466.0
439.6
431.7
431.1
409.0
Sex
Male
376.5
373.3
370.4
366.7
359.7
343.0
321.8
320.4
315.8
309.1
Female
387.0
370.9
368.6
357.0
366.8
344.1
332.1
325.2
332.9
314.9
Age
<18
63.1
37.8
42.8
68.7
34.1
29.2
29.7
36.3
19.2
33.2
0-4
227.5
143.8
194.7
91.4
94.3
71.2
116.9
5-11
12-17
28.9
46.7
34.3
18-44
106.0
103.0
103.1
108.2
96.3
92.8
73.8
79.7
72.6
81.4
18-24
95.6
70.3
60.2
45.8
64.9
55.7
55.4
40.9
46.9
25-44
107.1
106.6
107.6
114.5
99.5
96.8
78.3
82.3
75.5
84.6
45-64
214.9
204.5
214.3
210.0
212.8
198.5
189.9
191.4
188.1
182.2
45-54
164.9
157.7
175.8
161.7
166.7
156.7
144.5
142.6
140.7
138.2
55-64
250.4
236.4
240.1
241.8
241.9
225.2
217.7
222.0
208.8
65+
594.2
587.9
573.8
561.6
558.2
535.3
513.1
499.4
504.6
480.0
65-74
428.1
422.2
423.6
416.6
408.9
389.1
380.0
372.5
378.0
355.8
75-84
688.4
680.6
640.8
637.4
649.6
616.5
592.0
574.2
593.3
564.8
85+
1026.3
999.4
1003.6
939.8
910.9
917.6
869.7
883.3
864.1
865.0
Data Source: Special analyses, USRDS ESRD Database. Incident dialysis patients, unadjusted. “.” Zero values in this cell; *Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease .

22. HP2020 Table 18 CKD-14.3 Reduce the number of cardiovascular deaths for persons on dialysis: Target 81.3 deaths per 1,000 patient years at risk
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
95.6
90.3
85.6
82.8
80.0
76.7
74.3
71.5
67.8
67.0
Race
American Indian or Alaska Native
73.1
68.8
61.0
68.9
63.0
58.2
57.2
56.3
58.4
62.9
Asian
70.5
69.0
66.2
66.9
60.8
61.9
56.6
55.1
57.3
Native Hawaiian or Pacific Islander
88.0
79.2
71.3
79.9
78.6
66.6
65.7
62.4
60.2
59.2
Black/African American
77.3
72.4
69.5
66.7
63.1
59.6
57.1
54.4
White only
112.1
105.9
99.6
96.1
93.9
90.7
87.1
83.7
76.9
Two or more races
72.2
65.6
69.1
64.0
65.8
51.2
48.5
57.7
50.3
Ethnicity
Hispanic/Latino
72.7
67.3
64.5
65.0
61.3
59.1
56.0
Non-Hispanic
100.0
94.8
89.9
86.6
84.0
80.5
77.9
74.7
70.3
69.7
Non-Hispanic Black/African American
77.5
69.8
63.5
60.0
59.3
54.8
54.6
Non-Hispanic White
124.4
118.6
111.9
107.5
106.1
102.9
98.9
94.4
87.5
86.0
Sex
Male
96.5
91.1
87.3
85.0
81.6
78.4
76.3
73.2
68.0
Female
94.6
89.3
83.5
80.1
77.8
74.5
71.8
69.3
Age
<18
19.0
10.0
10.2
18.2
8.4
7.5
10.5
12.8 *
0-4
51.8
33.6
50.4
30.0
31.1
5-11
12-17
13.9
18-44
35.4
32.8
30.9
29.3
26.9
27.2
26.2
25.2
26.3
18-24
18.6
18.5
15.8
17.9
19.3
18.7
13.6
14.7
12.4
12.5
25-44
36.7
34.0
32.1
32.2
30.1
27.5
28.2
27.1
45-64
73.5
68.3
65.4
58.9
55.3
53.5
52.4
45-54
59.9
53.4
51.7
47.6
48.1
45.0
43.8
43.0
42.0
55-64
83.9
77.1
74.2
72.0
70.2
66.4
65.3
62.8
60.5
65+
140.6
134.1
126.4
121.3
117.6
112.3
107.8
102.8
94.1
65-74
115.0
108.9
104.8
101.7
97.0
93.3
90.0
86.9
81.2
75-84
158.0
152.2
140.2
132.6
131.1
117.8
113.5
106.0
102.6
85+
217.9
204.0
191.3
182.7
174.9
166.6
164.5
149.0
137.1
136.6
Data Source: Special analyses, USRDS ESRD Database. Period prevalent dialysis patients; unadjusted. *Values for cells with 10 or fewer patients are suppressed.

23. HP2020 Table 19 CKD-14.4 Reduce the total number of deaths for persons with a functioning kidney transplant: Target 27.8 deaths per 1,000 patient years at risk
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
31.5
30.9
29.7
31.0
30.8
31.1
31.4
31.3
32.3
32.7
Race
American Indian or Alaska Native
44.8
37.1
37.3
54.1
45.3
43.9
43.6
35.7
34.3
32.0
Asian
18.9
24.0
18.7
16.5
21.8
22.0
18.2
20.9
23.5
Native Hawaiian or Pacific Islander
18.0
16.4
16.7
26.8
17.4
17.7
21.2
26.5
24.6
Black/African American
34.0
30.1
30.2
30.4
30.3
White
31.9
32.1
32.2
32.5
33.8
Two or more races
20.4
15.0
22.4
23.7
25.8
28.9
Ethnicity
Hispanic/Latino
21.4
22.1
22.5
22.7
22.6
23.0
23.4
Non-Hispanic
29.3
30.0
31.6
34.1
34.7
Non-Hispanic Black/African American
28.2
27.8
29.5
30.6
Non-Hispanic White
31.7
32.4
32.8
36.6
Sex
Male
33.4
32.9
33.1
33.5
33.0
34.4
34.9
Female
28.7
28.3
27.3
28.8
27.7
28.1
28.4
29.2
Age
<18
3.9 *
3.0
3.5
6.4
2.6
4.3
0-4
5-11
12-17
6.2
18-44
11.3
10.4
9.5
9.8
8.9
8.1
7.8
7.4
7.6
6.9
18-24
8.2
5.9
5.8
6.3
4.2
4.7
3.6
5.4
25-44
11.7
10.9
9.9
10.2
9.2
8.6
7.1
45-64
29.8
28.0
27.1
27.6
25.6
25.2
24.7
24.8
45-54
21.9
19.1
16.6
16.0
55-64
39.5
38.1
35.3
34.6
32.6
65+
79.8
79.1
72.5
75.6
74.2
72.2
75.4
72.3
73.4
65-74
70.7
70.4
62.8
65.5
64.7
61.4
63.4
60.2
62.6
59.8
75-84
127.3
119.8
116.9
119.6
112.1
112.8
118.2
116.0
112.2
118.0
85+
149.0
214.5
135.3
146.5
165.8
159.0
195.7
167.2
189.7
186.5
Data Source: Special analyses, USRDS ESRD Database. Period prevalent transplant patients, unadjusted. *Values for cells with 10 or fewer patients are suppressed. Abbreviation: ESRD, end-stage renal disease.

24. HP2020 Table 20 CKD-14.5 Reduce the number of cardiovascular deaths in persons with a functioning kidney transplant: Target 4.5 deaths per 1,000 patient years at risk
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
All
5.1
5.0
4.0
4.1
4.2
3.4
3.3
2.9
2.6
2.7
Race
American Indian or Alaska Native *
Asian
3.6
3.7
1.8
2.1
2.2
1.3
2.4
Native Hawaiian or Pacific Islander
Black/African American
5.8
5.4
4.9
3.9
3.1
White
3.2
2.8
Two or more races
4.4
3.8
Ethnicity
Hispanic/Latino
4.3
1.9
Non-Hispanic
5.2
4.5
Non-Hispanic Black/African American
5.9
4.8
Non-Hispanic White
5.3
4.7
Sex
Male
5.7
3.0
Female
3.5
2.5
Age
<18
0-4
5-11
12-17
18-44
1.7
1.0
1.1
1.2
0.8
0.6
18-24
25-44
2.0
1.4
0.9
0.5
45-64
5.5
45-54
55-64
7.0
65+
11.5
11.6
8.3
9.4
9.1
7.2
5.6
65-74
9.9
10.2
7.6
8.2
8.6
6.8
6.2
75-84
20.3
18.0
15.4
10.9
7.3
85+
16.4
Data Source: Special analyses, USRDS ESRD Database. Period prevalent transplant patients, unadjusted. “.” Zero values in this cell; *Values for cells with 10 or fewer patients are suppressed. Abbreviation: CKD, chronic kidney disease.